Skip to main content
A Singapore Government Agency Website How to identify
Official website links end with .gov.sg
Secure websites use HTTPS
Look for a lock () or https:// as an added precaution. Share sensitive information only on official, secure websites.
Note: TRUST is supporting use cases across the local healthcare sector.

Click here to view our use cases.

TRUST Platform
Project (Active)

Singapore Lymphoma Study: Insights into Lymphoma Epidemiology and Outcomes in Singapore

6 March 2026

Main Applicant – Dr Woo Xing Yi, Senior Principal Scientist, Bioinformatics Institute, Agency for Science, Technology and Research (A*STAR)

Lymphomas is the 6th most common cancer in Singapore. This study focuses on two major aims: first, to analyse population-level incidence and survival trends in lymphoma subtypes in Singapore over time; and second, to identify the key lifestyle and clinical factors that influence patient outcomes. First, we will utilize data from Singapore Cancer Registry to explore trends in lymphoma subtypes compared to other cancer types to better understand their prevalence, incidence, and distribution longitudinally and across various demographics.

Subsequently, we aim to link health and socioeconomic records in MOH TRUST to investigate trends in lymphoma subtypes to better understand their prevalence, incidence, and distribution longitudinally and across various demographics. This analysis will also reveal specific clinical and sociodemographic drivers including disease pathology, treatment regimens, as well as ethnicity, socioeconomic status and geographic factors on patient outcomes.